query
ai
Login
Registrieren
Infos
Werben auf fleebs.com
Seite indizieren lassen
Einstellungen
Datenschutz
Nutzungsbedingungen
Impressum
Details werden geladen...
https://www.medscape.com/viewarticle/fda-approves-durvalumab-enfortumab-vedotin-mibc-2026a10018fj
Teilen bei
Facebook
Teilen bei
Twitter
Teilen bei
Pinterest
Per Mail empfehlen
FDA Approves Durvalumab With Enfortumab Vedotin for MIBC
With the approval, there's a rival to perioperative pembrolizumab with enfortumab vedotin for patients with cisplatin-ineligible muscle-invasive bladder cancer.
Ähnliche Seiten
FDA Approves Dostarlimab for Rectal Cancer
https://www.medscape.com/viewarticle/fda-approves-dostarlimab-rectal-cancer-2026a10013c7
FDA Approves First Generic Hormone Therapy Patch
https://www.medscape.com/viewarticle/fda-approves-generic-hormone-therapy-patch-menopause-2026a10013v9
Intratumoral Immunotherapy Draws Attention but Does It Work?
https://www.medscape.com/viewarticle/intratumoral-immunotherapy-draws-renewed-attention-does-it-2026a10012vx
FDA Expands Talazoparib Combo Indication in Prostate Cancer
https://www.medscape.com/viewarticle/fda-expands-talazoparib-combo-indication-prostate-cancer-2026a10014gv
FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults
https://www.medscape.com/viewarticle/fda-approves-tildrakizumab-psoriatic-arthritis-adults-2026a10015fb
FDA Expands Anktiva Approval in Bladder Cancer
https://www.medscape.com/viewarticle/fda-expands-anktiva-approval-bladder-cancer-2026a10012nh
Please enable JavaScript to continue using this application.